OFIX — Orthofix Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual income statement for Orthofix Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	407	464	461	747	799
Cost of Revenue
Gross Profit	305	350	337	486	546
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	413	473	474	886	884
Operating Profit	-6.27	-8.31	-13.3	-139	-84.6
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.368	-13.5	-17.7	-149	-124
Provision for Income Taxes
Net Income After Taxes	2.52	-38.4	-19.7	-151	-126
Net Income Before Extraordinary Items
Net Income	2.52	-38.4	-19.7	-151	-126
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2.52	-38.4	-19.7	-151	-126
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.13	-1.48	-0.905	-3.03	-2.63